June 2015
Volume 56, Issue 7
ARVO Annual Meeting Abstract  |   June 2015
Multicenter Clinical Trial of Ultrasonic Circular Cyclo Coagulation in glaucoma patients without previous filtering surgery
Author Affiliations & Notes
  • Florent Aptel
    Grenoble University Hospital, Grenoble, France
  • Philippe Denis
    Department of Ophthalmology, University Hospital, Hospices Civils de Lyon, Lyon, France
  • Jean-Francois J Rouland
    Department of Ophthalmology, Hôpital Claude Huriez, CHRU de Lille, Lille, France
  • Jean-Paul G Renard
    Department of Ophthalmology, HIA du Val de Grâce, Paris, France
  • Alain M Bron
    Department of Ophthalmology, University Hospital, CHU Dijon, Dijon, France
  • Footnotes
    Commercial Relationships Florent Aptel, EyeTechCare S.A. (F); Philippe Denis, EyeTechCare S.A. (F); Jean-Francois Rouland, EyeTechCare S.A. (F); Jean-Paul Renard, None; Alain Bron, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 6128. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Florent Aptel, Philippe Denis, Jean-Francois J Rouland, Jean-Paul G Renard, Alain M Bron; Multicenter Clinical Trial of Ultrasonic Circular Cyclo Coagulation in glaucoma patients without previous filtering surgery. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):6128.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: To evaluate the efficacy and safety of the Ultrasonic Circular Cyclo Coagulation (UC3) procedure in patients with open-angle glaucoma naïve of previous filtering surgery.

Methods: Prospective non comparative interventional clinical study performed in 5 French glaucoma centers. Thirty eyes of 30 patients with open-angle glaucoma, intraocular pressure (IOP) > 21 mmHg and with no previous filtering glaucoma surgeries were sonicated with a therapy probe comprising 6 piezoelectric transducers. The 6 transducers were activated with a 6 seconds exposure time. Complete ophthalmic examinations were performed before the procedure, and at 1 day, 1 week, 1, 2, 3, 6 and 12 months after. Primary outcomes were surgical success (defined as IOP reduction from baseline ≥ 20% and IOP > 5 mmHg with possible re-intervention and without hypotensive medications adjunction) at the last follow-up visit, and vision-threatening complications. Secondary outcomes were mean IOP at each follow-up visits compared to baseline, medication use, complications, and re-interventions.

Results: IOP was significantly reduced (p<0.05), from a mean preoperative value of 28.2 ± 7.2 mmHg (n= 3.6 hypotensive medications) to a mean value of 19.6 ± 7.9 mmHg at 12 months (n= 3.1 hypotensive medications and n= 1.2 procedures) (mean IOP reduction of 30%). Success was achieved in 66% of eyes (19/30) at 12 months (mean IOP reduction of 37% in these same eyes). No major intra- or post-operative complications occurred.

Conclusions: UC3 procedure is an effective and well-tolerated method to reduce intraocular pressure in patients with open-angle glaucoma without previous filtering surgery.


This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.